ANIK Anika Therapeutics, Inc.: institutional ownership and insider trading
146 funds reported holding $189M of Anika Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net sold $1.83M, with 17 new positions and 12 funds selling out; over the last 12 months insiders bought $264K and sold $0 on the open market; over its last four quarters it reported revenue of $121M and net income of −$3.90M.
ANIK revenue and earnings
- Quarter ended Jun 30, 2026: revenue $32.6M, net income $3.31M, EPS 0.24
- Quarter ended Mar 31, 2026: revenue $29.6M, net income −$5.06M, EPS -0.37
- Quarter ended Dec 31, 2025: revenue $30.6M, net income $172K, EPS 0.02
- Quarter ended Sep 30, 2025: revenue $27.8M, net income −$2.33M, EPS -0.16
Famous investors holding ANIK
- Renaissance Technologies (Renaissance Technologies): $7.04M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $3.70M, 0.0% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $3.59M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $211K, 0.0% of the portfolio
Largest institutional holders of ANIK
- BlackRock, Inc. (BLK) — $21.2M
- Caligan Partners LP — $21.0M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $8.99M
- ACADIAN ASSET MANAGEMENT LLC — $8.87M
- VANGUARD CAPITAL MANAGEMENT LLC — $8.37M
- AQR CAPITAL MANAGEMENT LLC — $8.19M
- BOOTHBAY FUND MANAGEMENT, LLC — $7.75M
- VANGUARD GROUP INC — $7.49M
- RENAISSANCE TECHNOLOGIES LLC — $7.04M
- DIMENSIONAL FUND ADVISORS LP — $6.60M
Recent ANIK insider trades
- Aug 4, 2026: Fischetti Gary P bought 2,000 shares ($41.1K)
- May 1, 2026: Henneman John B Iii bought 5,000 shares ($73.3K)
- Apr 30, 2026: Griffin Stephen D. bought 12,200 shares ($150K)
5%+ owners
- Caligan Partners LP: 10.0% (Schedule 13D/A, filed Jan 27, 2026)
- BlackRock, Inc.: 6.8% (Schedule 13G/A, filed Apr 17, 2025)
Who owns the most ANIK stock?
The largest institutional holders of Anika Therapeutics, Inc. in the latest 13F filings are BlackRock, Inc. (BLK) ($21.2M), Caligan Partners LP ($21.0M), MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) ($8.99M).
Are insiders buying or selling ANIK?
Over the last 12 months insiders bought $264K and sold $0 of Anika Therapeutics, Inc. stock on the open market (SEC Form 4).
Which famous investors own ANIK?
Renaissance Technologies, Two Sigma, D. E. Shaw, Izzy Englander.
What was ANIK's revenue last quarter?
Anika Therapeutics, Inc. reported revenue of $32.6M for the quarter ended June 30, 2026, with net income of $3.31M.